02 March 1998
Atherogenesis in IDDM: a family study of contributing factors
Henryk W. Witas, Wojciech Młynarski, Marcin Różycki, Krystyna Jedrychowska-Dańska, Dorota Cedzyńska, Cezary Watała, Jerzy BodalskiMed Sci Monit 1998; 4(2): CR255-262 :: ID: 502593
Abstract
Parameters of significance in atherogenesis were investigated in IDDM children (n=45), their parents (n=65) and siblings (n=17) as well as in unrelated healthy controls (n=51), their HLA DQ status, and the relationship between groups on the basis of discriminant analysis was established. Level of plasma lipids (total, HDL, LDL cholesterol, triglycerides and Lp (a) lipoprotein, markers of platelet activation (GMP-140, GPIIb/IIIa, microparticles, platelet aggregates) and fibrinolysis (tissue type plasminogen activator - t - PA and inhibitor - PAI-1 as well as its active form) were measured. Slight elevation of plasma lipids in IDDM patients in comparison to controls and siblings was not significant. The group of parents was characterized by the highest level of lipids, especially compared to controls (LDL p=0.03 and total cholesterol p=0.004). A tendency to a decrease of both plasminogen inhibitors (PAI-1 and its active form), as well as its activator (t-PA) concentration in the IDDM group was observed. However, the fraction of activated platelets in IDDM was dramatically enhanced (7.5±2.3% of cell population) in contrast to parents - 1.5±0.2% (p=0.002), siblings - 1.3±0.2% (NS), and controls - 1.4±0.2% (p=0.003). Similarly an elevation of platelet microparticles formation in the IDDM group, both before and after activation with thrombin, was observed. Stepwise discriminant analysis of the platelet parameter values revealed the highest discrepancy between the IDDM patients and controls (p=0.000001). Differences between IDDM children and their siblings (p=0.001) as well as parents (p=0.008) were less significant involvement of genetic factors affecting platelet response is suggested since the control group, represented by unrelated subjects, is particularly well separated from others more closely related. Analysis of the presence of HLA DQA152 and HLA DQB157 codons excludes their involvement in this altered platelet response. Data suggest that long lasting hyperglycemia in IDDM children is the most effective factor in atherogenic alterations, whereas in parents age-dependent factors are involved in the same type of changes.
Keywords: IDDM, PAI-1, t-PA, insulin-dependent diabetes mellitus, atherosclerosis, Platelet, Lipids
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
11 Mar 2024 : Clinical Research
Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective AdditiveMed Sci Monit In Press; DOI: 10.12659/MSM.942946
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952